DEERFIELD MANAGEMENT COMPANY, L.P. Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$4.1B
Holdings
105
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (105 positions)
| Stock | Value |
|---|---|
—INVITAE CORP | $267.7M |
—MYLAN NV | $196.9M |
—IMMUNOMEDICS INC | $196.0M |
—NEVRO CORP | $172.9M |
HZNPHORIZON THERAPEUTICS PUB L | $142.4M |
AFIBACUTUS MEDICAL INC | $129.4M |
—AERIE PHARMACEUTICALS INC | $120.1M |
—DFP HEALTHCARE ACQUISITNS CO | $114.3M |
CNCCENTENE CORP DEL | $106.6M |
—MYOKARDIA INC | $96.0M |
—NUVASIVE INC | $87.4M |
DXCM 0.75 12/01/23DEXCOM INC | $85.9M |
LRMRLARIMAR THERAPEUTICS INC | $78.0M |
NKTXNKARTA INC | $72.7M |
PCRXPACIRA BIOSCIENCES | $72.0M |
APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC | $69.7M |
—GRAYBUG VISION INC | $67.1M |
MIRMMIRUM PHARMACEUTICALS INC | $66.5M |
ALXNALEXION PHARMACEUTICALS INC | $66.3M |
INSM 1.75 01/15/25INSMED INC | $66.0M |
RVMDREVOLUTION MEDICINES INC | $62.5M |
SWTXSPRINGWORKS THERAPEUTICS INC | $58.8M |
OSH3EUROAK STR HEALTH INC | $50.8M |
ANNXANNEXON INC | $48.9M |
XLRNACCELERON PHARMA INC | $47.4M |
—INTERCEPT PHARMACEUTICALS IN | $46.5M |
B7SBROOKDALE SR LIVING INC | $45.0M |
—CLOVIS ONCOLOGY INC | $44.1M |
RETAEURREATA PHARMACEUTICALS INC | $43.6M |
RYTMRHYTHM PHARMACEUTICALS INC | $41.1M |
AXNX*AXONICS MODULATION TECHNOLOG | $39.6M |
2L9BLUEPRINT MEDICINES CORP | $37.6M |
AHCOADAPTHEALTH CORP | $37.3M |
ACHOWENS & MINOR INC NEW | $37.1M |
XERS 5 07/15/25XERIS PHARMACEUTICALS INC | $36.1M |
—DEERFIELD HEALTHCARE TECHNOL | $35.7M |
GKOSGLAUKOS CORP | $34.4M |
OPHTEURIVERIC BIO INC | $32.5M |
INZYINOZYME PHARMA INC | $30.2M |
GBIOGBXGENERATION BIO CO | $29.7M |
KODKODIAK SCIENCES INC | $29.4M |
QDELUSDQUIDEL CORP | $28.6M |
ORTXUSDORCHARD THERAPEUTICS PLC | $28.6M |
PBYIPUMA BIOTECHNOLOGY INC | $28.5M |
—BIODELIVERY SCIENCES INTL IN | $28.5M |
MOHMOLINA HEALTHCARE INC | $28.0M |
EDITEDITAS MEDICINE INC | $27.7M |
VCELVERICEL CORP | $27.6M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $27.1M |
FATEFATE THERAPEUTICS INC | $26.7M |
EHTHEHEALTH INC | $26.3M |
EP3ORASURE TECHNOLOGIES INC | $26.3M |
HOLXHOLOGIC INC | $25.8M |
—INTERSECT ENT INC | $25.7M |
MR4MERIDIAN BIOSCIENCE INC | $25.6M |
ADVMCHFADVERUM BIOTECHNOLOGIES INC | $24.8M |
—TCR2 THERAPEUTICS INC | $24.4M |
BDTXBLACK DIAMOND THERAPEUTICS I | $24.3M |
ACCDEURACCOLADE INC | $24.3M |
AMWLAMERICAN WELL CORP | $23.4M |
PTGXPROTAGONIST THERAPEUTICS INC | $23.1M |
—PACIRA BIOSCIENCES | $22.8M |
—LONGVIEW ACQUISITION CORP | $22.3M |
—CONSTELLATION PHARMCETICLS I | $20.4M |
NVRO 2.75 04/01/25NEVRO CORP | $18.8M |
NNOXNANO X IMAGING LTD | $17.9M |
—PTC THERAPEUTICS INC | $16.5M |
ALECALECTOR INC | $15.4M |
BCRXBIOCRYST PHARMACEUTICALS INC | $15.3M |
SLQTSELECTQUOTE INC | $15.2M |
NTRANATERA INC | $15.1M |
ARVNARVINAS INC | $14.5M |
ATNXEURATHENEX INC | $13.9M |
ARDXARDELYX INC | $13.4M |
RNAAVIDITY BIOSCIENCES INC | $13.3M |
TARAPROTARA THERAPEUTICS INC | $13.2M |
4NX1LUMOS PHARMA INC | $12.9M |
PRNPROFOUND MED CORP | $12.3M |
SEMSELECT MED HLDGS CORP | $11.8M |
—FUSION PHARMACEUTICALS INC | $11.7M |
—IMARA INC | $10.5M |
—ITAMAR MED LTD | $10.2M |
—HIGHCAPE CAP ACQUISITION COR | $10.1M |
ADCTADC THERAPEUTICS SA | $9.9M |
—METACRINE INC | $9.5M |
GOCOGOHEALTH INC | $9.1M |
—ATHIRA PHARMA INC | $8.3M |
DYNDYNE THERAPEUTICS INC | $8.3M |
SIENUSDSIENTRA INC | $7.9M |
STIMNEURONETICS INC | $7.7M |
—OXFORD IMMUNOTEC GLOBAL PLC | $7.3M |
OMGBPOUTSET MED INC | $6.3M |
—PANACEA ACQUISITION CORP | $6.0M |
AERIEURAERIE PHARMACEUTICALS INC | $5.8M |
TSHATAYSHA GENE THERAPIES INC | $5.6M |
—ARYA SCIENCES ACQUISTION CO | $5.5M |
CABACABALETTA BIO INC | $5.0M |
—GENMARK DIAGNOSTICS INC | $2.5M |
VKTXVIKING THERAPEUTICS INC | $2.0M |
—MALLINCKRODT PUB LTD CO | $1.9M |
Page 1 of 2Next